Unless I missed details of any upfront licensing fee, TJAB & co will be securing full Access Rights to ANP's antisense technology, in both know-how and intellectual property, at 'NO' cost. Please correct me if I've missed something?
There are no guarantees that clinical trials will proceed.
As I said before, (and I believe the details of the ATL1103 deal will also prove) the real value of a Biotech company can be measured by the value of its IP...
Wednesday 31 March 2010, London UK, Carlsbad, California - GlaxoSmithKline (GSK) and Isis Pharmaceuticals Inc. announced today a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new therapeutics against targets for rare and serious disease, including infectious diseases and some conditions causing blindness.Under the terms of the agreement, Isis will receive an upfront $35 million payment from GSK... - source
You may not be familiar with how business is conducted in China, skyrocketer, but let me enlighten you - All developments for devising legal protection over IP in the mainland are more rhetoric than reality - stealing IP is an elegant affair in modern PRC... with no shortage of scapegoats...
June 2012 Scientist Convicted of Stealing Merck Drugs A Chinese scientist employed by one of the country's primary pharmaceutical research firms was found guilty of stealing and selling patented medical compounds owned by Merck, according to a court document.
News of an alleged theft at a leading Chinese scientific research firm comes as the pharmaceutical industry increasingly looks to the world's most populous nation to help lower its high drug-development costs. A major hurdle, analysts say, is lax protection in China of intellectual property secrets...
Lewis Ho, a China-based partner with law firm Simmons & Simmons who specializes in the pharmaceutical industry, said he anticipates more security breaches as the industry turns to China. Outsourcing, he said, helps "drive down the R&D expense but in return you would not be able to have the same level of protection as with your own employees." - Wall Street Journal
Imho, the real value for ANP will soon be realized in the details of its licensing deal currently under negotiation for ATL1103
ANP Price at posting:
19.0¢ Sentiment: LT Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)